Although the results from animal studies cannot be directly applied to humans due to the genetic differences across the species, the effects of exenatide on hepatic steatosis in humans is one of the interesting and promising aspects of incretin that has to be clarified through well-designed clinical trials in humans. The gene discussed is GCG; the disease is Hepatic steatosis.